about
Efficacy and Safety of the Selective α1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in KoreaEffect of improvement in lower urinary tract symptoms on sexual function in men: tamsulosin monotherapy vs. combination therapy of tamsulosin and solifenacin.Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.Relationship between Serum Testosterone and Cardiovascular Disease Risk Determined Using the Framingham Risk Score in Male Patients with Sexual Dysfunction.Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensiSexual behavior of the elderly in urban areas.Prevalence of premature ejaculation in young and middle-aged men in Korea: a multicenter internet-based survey from the Korean Andrological SocietyEffects of low-dose tamsulosin on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Urologist's Practice Patterns Including Surgical Treatment in the Management of Premature Ejaculation: A Korean Nationwide Survey.Urologists' Perceptions and Practice Patterns in Peyronie's Disease: A Korean Nationwide Survey Including Patient Satisfaction.Spontaneous recovery of cavernous nerve crush injury.Efficacy and safety of a newly developed polylactic acid microsphere as an injectable bulking agent for penile augmentation: 18-months follow-up.Efficacy and safety of newly developed cross-linked dextran gel injection for glans penis augmentation with a novel technique.A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction.Efficacy of once-daily administration of udenafil for 24 weeks on erectile dysfunction: results from a randomized multicenter placebo-controlled clinical trial.Efficacy and safety of mirodenafil in men taking antihypertensive medications.The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study.Influence of Donor's Renal Function on the Outcome of Living Kidney Transplantation: 10-Year Follow-up.Long-Term Safety and Longevity of a Mixture of Polymethyl Methacrylate and Cross-Linked Dextran (Lipen-10®) after Penile Augmentation: Extension Study from Six to 18 Months of Follow-Up.Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.Chronic administration of udenafil, a selective phosphodiesterase type 5 inhibitor, promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury.Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat.Tolerability and efficacy of newly developed penile injection of cross-linked dextran and polymethylmethacrylate mixture on penile enhancement: 6 months follow-up.Localization of peripheral dopamine D1 and D2 receptors in rat and human seminal vesicles.The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats.AB65. Experience in the use of synthetic fillers in phalloplasty.The World Journal of Men's Health Has Been Accepted for Coverage in Science Citation Index (SCI) Expanded.Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study.Efficacy and safety of the simultaneous administration of mirodenafil and an α-blocker in men with BPH-LUTS: a multicenter open-label prospective study.Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.The effect and safety of polylactic acid and adipose-derived stromal vascular fraction cell as an injectable bulking agent in urologic field: a 24-week follow-up study.Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum.Can estimated intravaginal ejaculatory latency time be used interchangeably with stopwatch-measured intravaginal ejaculatory latency time for the diagnosis of lifelong premature ejaculation?Is It Worth Treating Non-Bothering Nocturia? Results of a Multicenter Prospective Observational StudyPostmicturition Dribble Is Associated with Erectile Dysfunction in Middle-Aged and Older Men with Lower Urinary Tract SymptomsA current perspective on post-micturition dribble in malesComparison of cadaveric pericardial, dermal, vein, and synthetic grafts for tunica albuginea substitution using a rat modelRelationship of renal implantation biopsies and acute rejection during the immediate posttransplantation periodDevelopment and validation of a symptom assessment tool for postmicturition dribble: A prospective, multicenter, observational study in KoreaChoroidal Thickness Analysis in Patients with Erectile Dysfunction
P50
Q33633716-0950C03C-7902-40A2-BFB0-D45632BD1DEEQ34196420-11374D3F-C953-4691-9649-33DE4E98C20DQ34797880-036A6151-1C3F-4F7D-8B89-7BA79E6BB1B6Q34984090-90C07EE4-9313-4C16-A682-9ED24358DB58Q35001406-6179FD67-75B6-4D46-AC23-B9467331E1FAQ36758154-8D37BD0C-7207-4F59-B944-E44255D7F041Q37084082-3F148A1C-A6AD-45B5-8849-678FA2FFFF4BQ37251847-81E90354-A602-41A4-81DF-769BD4219114Q37466594-E34AACF5-39E8-41C1-ACAE-133FF58BECD3Q37500114-B8C9E565-BBB2-4B0C-AE9B-D7FB965B48C8Q38263039-60E76C96-2B29-4E19-BF86-D80B811BE0C8Q38403631-7F411F73-0050-4E6C-ABA0-FACE511822FCQ38404793-5A7901FF-EAF7-49EC-80CF-3E4B8122BAD5Q38413324-0FA5D44F-59C4-456B-B66D-381F7845B3C8Q38428136-F6661654-1663-4849-8563-C4F74D9CF66BQ38483259-DD4E0883-9394-408A-8EBD-6A321ADBABC0Q38487266-003391F2-8F08-410B-ABB8-BB4241799DBBQ41499418-4B3F7D92-B41E-4D9F-BB86-30A247F7BC97Q42111048-015B199C-9276-48B3-9598-9790F81699F9Q42635834-B3A8F1CF-54FF-4D36-8F98-189CE330D7A0Q42747753-4ADA345D-9ACF-4C6F-ACEE-CA9BC24BC507Q43593439-C6DE830B-0301-4938-AB07-DA99F5BD87B9Q43660998-17D2AE07-59A6-4F82-A6B8-894B3EE899B5Q43849192-2B496689-D11E-4A27-AC81-B6BB18F5F313Q44591419-E005FE12-3785-409D-800B-0A39FA246C1FQ46627128-C91D0A0D-9204-4E3E-816A-2664DE7DA23AQ47098297-1DD94CF8-DFD5-458B-B2ED-ADAD41E20468Q50696107-D83AD76F-DF08-4F04-A083-7027DDA8A24EQ53117877-CCD00E5B-9CA1-40CE-B3D2-A7EED7E59BD4Q53155946-59F4EDD4-4A65-4A32-AB82-71DFEFA25B14Q53531048-DDF1072E-FA43-4981-AE92-C8033F3A761BQ54784574-4A741F37-2AB8-43EA-B4F7-F2574B954050Q57221610-FF664318-278B-4F55-9442-965E4B027FBFQ57575684-A402B2D9-D0DC-409D-AA17-F4E53218357CQ58727763-96BA01DB-AAE0-48AA-8EE2-F925D88CBF32Q64085712-BC3DF403-A057-47B4-A9DB-36D95D7A9811Q73567058-90AEE961-E151-437E-9CDF-9ACF706042C8Q77632078-E6C940AE-2734-4864-91C0-CFA58DD1358FQ90656184-719A6A3F-2186-4835-A125-631CC3A9DE9FQ90749466-A069CA9F-9CCF-4931-AD94-02E4EE2EA688
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dae Yul Yang
@ast
Dae Yul Yang
@en
Dae Yul Yang
@es
Dae Yul Yang
@nl
type
label
Dae Yul Yang
@ast
Dae Yul Yang
@en
Dae Yul Yang
@es
Dae Yul Yang
@nl
prefLabel
Dae Yul Yang
@ast
Dae Yul Yang
@en
Dae Yul Yang
@es
Dae Yul Yang
@nl
P106
P31
P496
0000-0002-7331-302X